Fangda Partners advised BeiGene, while Davis Polk advised the representatives of the several underwriters on the deal. BeiGene executed a US$3.5 billion initial public offering and listing...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here